X
Teva and Neos settle over Cotempla patent dispute
https://pharmaphorum.com/news/teva-and-neos-settle-over-cotempla-patent-dispute/
Patents
Will plausibility reign supreme in Lyrica second medical use patent case?
Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.
Local partnerships key to pharma’s success in China
China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.
Increasing access to medicines: A critical look at pharmaceutical patents
Extending patents is restricting patients’ access to the treatments they need.
Making the case for pharmaceutical IP management
IP management can protect pharma companies’ investments and future R&D.
Recent trends in ANDA litigation
Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
